Matthew P Pase1, Kendra Davis-Plourde2, Jayandra J Himali2, Claudia L Satizabal2, Hugo Aparicio2, Sudha Seshadri2, Alexa S Beiser2, Charles DeCarli2. 1. From the Melbourne Dementia Research Centre (M.P.P.), the Florey Institute for Neuroscience and Mental Health, the University of Melbourne, Australia; Department of Neurology (M.P.P., J.J.H., C.L.S., H.A., S.S., A.S.B), Boston University School of Medicine; Framingham Heart Study (M.P.P., K.D-.P., J.J.H., H.A., S.S., A.S.B., C.D.), MA; Centre for Human Psychopharmacology (M.P.P.), Swinburne University of Technology, Australia; Department of Biostatistics (K.D.-P., J.J.H., A.S.B.), Boston University School of Public Health, MA; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases (C.L.S., S.S., C.D.), University of Texas Health Sciences Center, San Antonio; and Department of Neurology, School of Medicine & Imaging of Dementia and Aging Laboratory, Center for Neuroscience, University of California Davis, Sacramento. matthewpase@gmail.com. 2. From the Melbourne Dementia Research Centre (M.P.P.), the Florey Institute for Neuroscience and Mental Health, the University of Melbourne, Australia; Department of Neurology (M.P.P., J.J.H., C.L.S., H.A., S.S., A.S.B), Boston University School of Medicine; Framingham Heart Study (M.P.P., K.D-.P., J.J.H., H.A., S.S., A.S.B., C.D.), MA; Centre for Human Psychopharmacology (M.P.P.), Swinburne University of Technology, Australia; Department of Biostatistics (K.D.-P., J.J.H., A.S.B.), Boston University School of Public Health, MA; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases (C.L.S., S.S., C.D.), University of Texas Health Sciences Center, San Antonio; and Department of Neurology, School of Medicine & Imaging of Dementia and Aging Laboratory, Center for Neuroscience, University of California Davis, Sacramento.
Abstract
OBJECTIVE: Given the potential therapeutic effect of vascular disease control timing to reduce dementia risk, we investigated the age-related influences of vascular risk factor burden on brain structure throughout the lifespan. METHODS: We studied participants from the community-based prospective Framingham Heart Study. Overall vascular risk factor burden was calculated according to the Framingham Stroke Risk Profile, a validated algorithm that predicts stroke risk. Brain volume was estimated by MRI. We used cross-sectional data to examine how the strength of association between vascular risk factor burden and brain volume changed across each age decade from age 45-54 years through to 85-94 years (N = 2,887). Second, we leveraged up to 40 years of longitudinal data to determine how the strength of association between vascular risk factor burden and brain volume changed when vascular risk factors were examined at progressively earlier ages (N = 7,868). RESULTS: In both cross-sectional and longitudinal analyses, higher vascular risk factor burden was associated with lower brain volume across each age decade. In the cross-sectional analysis, the strength of this association decreased with each decade of advancing age (p for trend < 0.0001). In longitudinal analysis, the strength of association between vascular risk factor burden and brain volume was stronger when vascular risk factors were measured at younger ages. For example, vascular risk factor burden was most strongly associated with lower brain volume in later life when vascular risk factors were measured at age 45 years. CONCLUSION: Vascular risk factors at younger ages appear to have detrimental effects on current and future brain volume.
OBJECTIVE: Given the potential therapeutic effect of vascular disease control timing to reduce dementia risk, we investigated the age-related influences of vascular risk factor burden on brain structure throughout the lifespan. METHODS: We studied participants from the community-based prospective Framingham Heart Study. Overall vascular risk factor burden was calculated according to the Framingham Stroke Risk Profile, a validated algorithm that predicts stroke risk. Brain volume was estimated by MRI. We used cross-sectional data to examine how the strength of association between vascular risk factor burden and brain volume changed across each age decade from age 45-54 years through to 85-94 years (N = 2,887). Second, we leveraged up to 40 years of longitudinal data to determine how the strength of association between vascular risk factor burden and brain volume changed when vascular risk factors were examined at progressively earlier ages (N = 7,868). RESULTS: In both cross-sectional and longitudinal analyses, higher vascular risk factor burden was associated with lower brain volume across each age decade. In the cross-sectional analysis, the strength of this association decreased with each decade of advancing age (p for trend < 0.0001). In longitudinal analysis, the strength of association between vascular risk factor burden and brain volume was stronger when vascular risk factors were measured at younger ages. For example, vascular risk factor burden was most strongly associated with lower brain volume in later life when vascular risk factors were measured at age 45 years. CONCLUSION: Vascular risk factors at younger ages appear to have detrimental effects on current and future brain volume.
Authors: Charles DeCarli; Joseph Massaro; Danielle Harvey; John Hald; Mats Tullberg; Rhoda Au; Alexa Beiser; Ralph D'Agostino; Philip A Wolf Journal: Neurobiol Aging Date: 2005-04 Impact factor: 4.673
Authors: Ramachandran S Vasan; Joseph M Massaro; Peter W F Wilson; Sudha Seshadri; Philip A Wolf; Daniel Levy; Ralph B D'Agostino Journal: Circulation Date: 2002-01-01 Impact factor: 29.690
Authors: S Seshadri; P A Wolf; A Beiser; R S Vasan; P W Wilson; C S Kase; M Kelly-Hayes; W B Kannel; R B D'Agostino Journal: Arch Intern Med Date: 2001-10-22
Authors: Philip B Gorelick; Karen L Furie; Costantino Iadecola; Eric E Smith; Salina P Waddy; Donald M Lloyd-Jones; Hee-Joon Bae; Mary Ann Bauman; Martin Dichgans; Pamela W Duncan; Meighan Girgus; Virginia J Howard; Ronald M Lazar; Sudha Seshadri; Fernando D Testai; Stephen van Gaal; Kristine Yaffe; Hank Wasiak; Charlotte Zerna Journal: Stroke Date: 2017-09-07 Impact factor: 7.914
Authors: Paola Gilsanz; Elizabeth Rose Mayeda; M Maria Glymour; Charles P Quesenberry; Dan M Mungas; Charles DeCarli; Alexander Dean; Rachel A Whitmer Journal: Neurology Date: 2017-10-04 Impact factor: 9.910
Authors: Isabelle Pelcher; Christian Puzo; Yorghos Tripodis; Hugo J Aparicio; Eric G Steinberg; Alyssa Phelps; Brett Martin; Joseph N Palmisano; Elizabeth Vassey; Cutter Lindbergh; Ann C McKee; Thor D Stein; Ronald J Killiany; Rhoda Au; Neil W Kowall; Robert A Stern; Jesse Mez; Michael L Alosco Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Sarah Gauci; Lauren M Young; Lizanne Arnoldy; Andrew Scholey; David J White; Annie-Claude Lassemillante; Denny Meyer; Andrew Pipingas Journal: Front Nutr Date: 2022-04-28
Authors: Vanessa H Brait; David K Wright; Mohsen Nategh; Alexander Oman; Warda T Syeda; Charlotte M Ermine; Katrina R O'Brien; Emilio Werden; Leonid Churilov; Leigh A Johnston; Lachlan H Thompson; Jess Nithianantharajah; Katherine A Jackman; Amy Brodtmann Journal: Sci Rep Date: 2021-05-13 Impact factor: 4.379
Authors: Kristen M George; Paola Gilsanz; Rachel L Peterson; Lisa L Barnes; Charles S DeCarli; Elizabeth Rose Mayeda; Dan M Mungas; Rachel A Whitmer Journal: J Gerontol A Biol Sci Med Sci Date: 2021-08-13 Impact factor: 6.591
Authors: Simon R Cox; Donald M Lyall; Stuart J Ritchie; Mark E Bastin; Mathew A Harris; Colin R Buchanan; Chloe Fawns-Ritchie; Miruna C Barbu; Laura de Nooij; Lianne M Reus; Clara Alloza; Xueyi Shen; Emma Neilson; Helen L Alderson; Stuart Hunter; David C Liewald; Heather C Whalley; Andrew M McIntosh; Stephen M Lawrie; Jill P Pell; Elliot M Tucker-Drob; Joanna M Wardlaw; Catharine R Gale; Ian J Deary Journal: Eur Heart J Date: 2019-07-21 Impact factor: 29.983
Authors: Kumar B Rajan; Neelum T Aggarwal; Elizabeth A McAninch; Jennifer Weuve; Lisa L Barnes; Robert S Wilson; Charles DeCarli; Denis A Evans Journal: Ann Neurol Date: 2020-09-29 Impact factor: 11.274
Authors: Christopher A Lane; Josephine Barnes; Jennifer M Nicholas; Carole H Sudre; David M Cash; Thomas D Parker; Ian B Malone; Kirsty Lu; Sarah-Naomi James; Ashvini Keshavan; Heidi Murray-Smith; Andrew Wong; Sarah M Buchanan; Sarah E Keuss; Elizabeth Gordon; William Coath; Anna Barnes; John Dickson; Marc Modat; David Thomas; Sebastian J Crutch; Rebecca Hardy; Marcus Richards; Nick C Fox; Jonathan M Schott Journal: Lancet Neurol Date: 2019-08-20 Impact factor: 44.182